Aristotle University Of Thessaloniki (AUTH)
Novel adipomyokines and growth factors in breast cancer
Abstract
dc:descriptionPurpose: Obesity and physical inactivity are now considered independent risk factors for development of malignancies. Insulin resistance and overproduction of growth factors and other cytokines or hormones secreted from adipose-tissue and termed adipokines, which exert direct effects on the cell cycle, are among the molecular mechanisms suggested to bridge this relationship, as previously suggested pathways cannot fully explain the epidemiological link. More recently, muscle tissue was also shown to synthesize and secrete molecules, named myokines, that may also play a role in carcinogenesis. Therefore, we aimed at investigating the role of novel adipomyokines and growth factors in breast neoplasms by conducting the following: Methods: In vitro experiments using breast cancer cell lines were employed to assess the effects of recombinant irisin on cell viability, induction of apoptosis and cell death, as well as migration potential. In a clinical study protocol, adult females with recent diagnosis of benign or malignant proliferative diseases, scheduled for surgical removal of the tumor, and healthy controls from the same population were recruited from the same clinic, and the total study sample was studied in a case-control manner. Demographic and anthropometric parameters and medical history data, together with tumor pathology characteristics, were individually recorded. In two different clinical studies, serum samples were assayed for irisin, omentin-1 (Clinical Study A), and follistatin, follistatin-like 3 (FSTL-3), activin A, activin B, growth factors and pregnancy associated plasma protein-A (PAPP-A) (Clinical Study B) using commercially available ELISA kits. Results: In vitro, irisin treatment reduced cell viability by increasing apoptotic pathways and inducing cell death (ANOVA, p < 0.05 for all), but it did not affect the migration potential of breast cancer cells. In clinical study A, women with breast neoplasms had higher serum irisin concentration compared to healthy controls (18.2 ± 4.7 ng/mL vs. 15.6 ± 3.3 ng/mL, respectively; p < 0.01). Irisin concentration was positively associated with tumor behavior characteristics, including Ki67 percentage (r = 0.28, p = 0.03). This protein showed an increasing pattern with Elston-Ellis grading system (grade 1: 12.4 ± 0.1 ng/ml vs. grade 2: 17.4 ± 4.2 ng/ml vs. grade 3: 20.0 ± 5.1 ng/ml; ANOVA, p = 0.01; grade 1 vs. grade 3, p = 0.03 after post-hoc Bonferroni correction) Patients with estrogen receptor positive breast malignancy exhibited lower irisin concentrations compared to estrogen receptor negative breast cancer patients (17.84 ± 4.84 ng/ml vs. 19.99 ± 3.69 ng/ml, respectively, p = 0.04). In clinical study B, in multivariate models adjusting for potential covariates serum total insulin-like growth factor 1 binding protein 4 (IGFBP-4) concentrations were an independent predictor of the presence of malignancy [Odds Ratio (OR) 1.01 (95% Confidence Interval (CI): 1.004, 1.02); p = 0.01]; furthermore, serum FSTL-3 concentrations could distinguish between benign tumor and malignancy [OR 6.61 (95% CI: 1.70, 25.70); p < 0.01] and were positively associated with tumor size. [Standardized β 0.44 (95% CI: 0.19, 1.27); p = 0.01]. Conclusions: Serum concentrations of irisin, FSTL-3 and total IGFBP-4 are increased in breast neoplasms. This thesis warrants further studies to evaluate whether these proteins may hold potential as future diagnostic, prognostic factors or therapeutic targets in breast carcinogenesis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Panagiotou, Grigorios
- Παναγιώτου, Γρηγόριος
Subjects
dc:subject × 18- Λιπομυοκίνες
- Φυσική δραστηριότητα
- Παχυσαρκία
- Ογκογένεση
- Adipomyokines
- Physical activity
- Obesity
- Oncogenesis
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Βασική Ιατρική
- Φαρμακολογία και Φαρμακευτική
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
- Basic Medicine
- Pharmacology and Pharmacy
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49095